Position in ZTS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$22,241,173
-$109,320,055 QoQ
Shares Held
309,507
-72.2% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#149
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ninety One UK Ltd holds $22,286,847 across 2 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (99.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
309,507 | $22,241,173 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
271 | $45,674 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,241,173 | 309,507 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $131,561,228 | 1,112,945 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $144,205,573 | 1,146,126 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $163,751,394 | 1,119,132 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $145,882,803 | 935,446 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $180,757,709 | 1,097,830 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $275,171,010 | 1,688,891 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $327,569,614 | 1,676,577 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $53,163,097 | 306,663 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $21,153,788 | 125,015 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $21,373,789 | 108,293 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $16,659,628 | 95,756 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $16,490,140 | 95,756 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $16,099,075 | 96,726 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $12,113,676 | 82,659 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $12,952,538 | 87,346 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,981,816 | 92,977 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,807,044 | 94,422 | Shares | Sole | 2022-05-26 | |
| 2021-12-31 | $20,664,460 | 84,680 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $14,670,771 | 75,568 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $14,327,356 | 76,880 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $12,433,046 | 78,950 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $13,342,610 | 80,620 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $12,934,745 | 78,217 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $12,571,912 | 91,739 | Shares | Sole | 2020-09-04 | |
| 2020-03-31 | $11,360,851 | 96,532 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||